12 Nov 2020 07:00
Arix Bioscience PLC (ARIX) Arix to Present at the Jefferies Virtual London Healthcare Conference 12-Nov-2020 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Arix Bioscience plc
Arix to Present at the Jefferies Virtual London Healthcare Conference
LONDON, 12 November 2020: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company focused on investing and building breakthrough biotech companies, today announces that Dr. Naseem Amin, Executive Chairman, is scheduled to participate in an analyst led fireside chat at the Jefferies Virtual London Healthcare Conference on Tuesday, 17 November 2020, at 10:35am GMT.
A live webcast of the fireside chat will be available on the investor relations section of Arix's website at https://arixbioscience.com/investor-relations/events-presentations. After the conference, an archived replay will be available on the company's website at the same address.
[ENDS]
Enquiries For more information on Arix, please contact:
Arix Bioscience plc Charlotte Parry, Head of Investor Relations +44 (0)20 7290 1072 charlotte@arixbioscience.com
Optimum Strategic Communications Supriya Mathur, Shabnam Bashir, Manel Mateus +44 (0)20 3922 1906 optimum.arix@optimumcomms.com
About Arix Bioscience plc Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting-edge advances in life sciences.
We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.
For more information please visit: www.arixbioscience.com |
| ISIN: | GB00BD045071 |
| Category Code: | MSCM |
| TIDM: | ARIX |
| LEI Code: | 213800OVT3AHQCXNIX43 |
| OAM Categories: | 3.1. Additional regulated information required to be disclosed under the laws of a Member State |
| Sequence No.: | 87702 |
| EQS News ID: | 1147540 |
| End of Announcement | EQS News Service |
UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.